Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic syndrome; the key factor influencing its prognosis is the progression of liver fibrosis. This review aimed to propose a practical and stepwise appro...
Saved in:
| Published in: | World journal of gastroenterology : WJG Vol. 26; no. 39; p. 5919 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
21.10.2020
|
| Subjects: | |
| ISSN: | 2219-2840, 2219-2840 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic syndrome; the key factor influencing its prognosis is the progression of liver fibrosis. This review aimed to propose a practical and stepwise approach to the evaluation and management of liver fibrosis in patients with NAFLD, analyzing the currently available literature. In the assessment of NAFLD patients, it is important to identify clinical, genetic, and environmental determinants of fibrosis development and its progression. To properly detect fibrosis, it is important to take into account the available methods and their supporting scientific evidence to guide the approach and the sequential selection of the best available biochemical scores, followed by a complementary imaging study (transient elastography, magnetic resonance elastography or acoustic radiation force impulse) and finally a liver biopsy, when needed. To help with the selection of the most appropriate method a Fagan's nomogram analysis is provided in this review, describing the diagnostic yield of each method and their post-test probability of detecting liver fibrosis. Finally, treatment should always include diet and exercise, as well as controlling the components of the metabolic syndrome, +/- vitamin E, considering the presence of sleep apnea, and when available, allocate those patients with advanced fibrosis or high risk of progression into clinical trials. The final end of this approach should be to establish an opportune diagnosis and treatment of liver fibrosis in patients with NAFLD, aiming to decrease/stop its progression and improve their prognosis. |
|---|---|
| AbstractList | Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic syndrome; the key factor influencing its prognosis is the progression of liver fibrosis. This review aimed to propose a practical and stepwise approach to the evaluation and management of liver fibrosis in patients with NAFLD, analyzing the currently available literature. In the assessment of NAFLD patients, it is important to identify clinical, genetic, and environmental determinants of fibrosis development and its progression. To properly detect fibrosis, it is important to take into account the available methods and their supporting scientific evidence to guide the approach and the sequential selection of the best available biochemical scores, followed by a complementary imaging study (transient elastography, magnetic resonance elastography or acoustic radiation force impulse) and finally a liver biopsy, when needed. To help with the selection of the most appropriate method a Fagan's nomogram analysis is provided in this review, describing the diagnostic yield of each method and their post-test probability of detecting liver fibrosis. Finally, treatment should always include diet and exercise, as well as controlling the components of the metabolic syndrome, +/- vitamin E, considering the presence of sleep apnea, and when available, allocate those patients with advanced fibrosis or high risk of progression into clinical trials. The final end of this approach should be to establish an opportune diagnosis and treatment of liver fibrosis in patients with NAFLD, aiming to decrease/stop its progression and improve their prognosis.Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic syndrome; the key factor influencing its prognosis is the progression of liver fibrosis. This review aimed to propose a practical and stepwise approach to the evaluation and management of liver fibrosis in patients with NAFLD, analyzing the currently available literature. In the assessment of NAFLD patients, it is important to identify clinical, genetic, and environmental determinants of fibrosis development and its progression. To properly detect fibrosis, it is important to take into account the available methods and their supporting scientific evidence to guide the approach and the sequential selection of the best available biochemical scores, followed by a complementary imaging study (transient elastography, magnetic resonance elastography or acoustic radiation force impulse) and finally a liver biopsy, when needed. To help with the selection of the most appropriate method a Fagan's nomogram analysis is provided in this review, describing the diagnostic yield of each method and their post-test probability of detecting liver fibrosis. Finally, treatment should always include diet and exercise, as well as controlling the components of the metabolic syndrome, +/- vitamin E, considering the presence of sleep apnea, and when available, allocate those patients with advanced fibrosis or high risk of progression into clinical trials. The final end of this approach should be to establish an opportune diagnosis and treatment of liver fibrosis in patients with NAFLD, aiming to decrease/stop its progression and improve their prognosis. Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic syndrome; the key factor influencing its prognosis is the progression of liver fibrosis. This review aimed to propose a practical and stepwise approach to the evaluation and management of liver fibrosis in patients with NAFLD, analyzing the currently available literature. In the assessment of NAFLD patients, it is important to identify clinical, genetic, and environmental determinants of fibrosis development and its progression. To properly detect fibrosis, it is important to take into account the available methods and their supporting scientific evidence to guide the approach and the sequential selection of the best available biochemical scores, followed by a complementary imaging study (transient elastography, magnetic resonance elastography or acoustic radiation force impulse) and finally a liver biopsy, when needed. To help with the selection of the most appropriate method a Fagan's nomogram analysis is provided in this review, describing the diagnostic yield of each method and their post-test probability of detecting liver fibrosis. Finally, treatment should always include diet and exercise, as well as controlling the components of the metabolic syndrome, +/- vitamin E, considering the presence of sleep apnea, and when available, allocate those patients with advanced fibrosis or high risk of progression into clinical trials. The final end of this approach should be to establish an opportune diagnosis and treatment of liver fibrosis in patients with NAFLD, aiming to decrease/stop its progression and improve their prognosis. |
| Author | Ruiz-Margáin, Astrid González-Regueiro, José A Macías-Rodríguez, Ricardo U Campos-Murguía, Alejandro |
| Author_xml | – sequence: 1 givenname: Alejandro surname: Campos-Murguía fullname: Campos-Murguía, Alejandro organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico – sequence: 2 givenname: Astrid surname: Ruiz-Margáin fullname: Ruiz-Margáin, Astrid organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico – sequence: 3 givenname: José A surname: González-Regueiro fullname: González-Regueiro, José A organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico – sequence: 4 givenname: Ricardo U surname: Macías-Rodríguez fullname: Macías-Rodríguez, Ricardo U organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33132645$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLAzEURoMo9qF7V5KlmxknN8k0WUrxBQU33bga8qwpmUydTCv99w5awdX9Lt_hcrgzdJ665BC6IVVJF0zcf2035QHqMlBZcknkGZoCEFmAYNX5vzxBs5y3VQWUcrhEE0oJhZrxKXpfxpCCURGrnF3OrUsDVsniViW1cT9r53EMB9djH3Tf5ZBxSHg0KVQ03UcXg8FeDcPxRNmQncruCl14FbO7Ps05Wj89rpcvxert-XX5sCrMqDAUGrymTC2sIFZIYYQwWkiwlbTgCVSUEAbMcqO59ppJJTzoyo6V1qTWMEd3v2d3ffe5d3lo2pCNi1El1-1zA4zXgjPC5YjentC9bp1tdn1oVX9s_r4B35w0ZSk |
| CitedBy_id | crossref_primary_10_1080_17474124_2021_1974295 crossref_primary_10_1186_s12933_025_02818_1 crossref_primary_10_1016_j_heliyon_2023_e16652 crossref_primary_10_3390_nu13113679 crossref_primary_10_1016_j_jrras_2025_101647 crossref_primary_10_1080_13880209_2022_2106250 crossref_primary_10_3390_foods10091973 crossref_primary_10_1093_cid_ciaf049 crossref_primary_10_1186_s12876_025_03770_w crossref_primary_10_1155_ije_6664846 crossref_primary_10_21518_ms2025_098 crossref_primary_10_3390_jcm14145117 crossref_primary_10_7759_cureus_43635 crossref_primary_10_1007_s10863_022_09953_4 crossref_primary_10_1016_j_lfs_2024_122505 crossref_primary_10_2217_epi_2023_0146 crossref_primary_10_1089_bari_2022_0043 crossref_primary_10_3390_jpm13050830 crossref_primary_10_3389_fimmu_2024_1455383 crossref_primary_10_1097_MD_0000000000040214 crossref_primary_10_1038_s41598_022_18718_3 crossref_primary_10_4292_wjgpt_v15_i6_97381 crossref_primary_10_3390_livers4040046 crossref_primary_10_3748_wjg_v27_i33_5502 crossref_primary_10_1186_s12876_025_03612_9 crossref_primary_10_1007_s11695_022_06251_1 crossref_primary_10_1097_HEP_0000000000000043 crossref_primary_10_1097_CPT_0000000000000224 crossref_primary_10_1177_20420188211055557 crossref_primary_10_1016_j_intimp_2023_110550 crossref_primary_10_3748_wjg_v30_i45_4791 crossref_primary_10_3390_nu15163520 crossref_primary_10_3390_diagnostics13132187 crossref_primary_10_1155_jfbc_1906540 crossref_primary_10_3390_ijms22094459 crossref_primary_10_12677_tcm_2024_136177 crossref_primary_10_2174_1574885518666230417111247 crossref_primary_10_2463_mrms_mp_2024_0080 crossref_primary_10_3390_ijerph19031675 crossref_primary_10_1007_s13679_024_00574_z crossref_primary_10_3390_jcm12030979 crossref_primary_10_2147_DMSO_S439127 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Copyright_xml | – notice: The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.3748/wjg.v26.i39.5919 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 2219-2840 |
| ExternalDocumentID | 33132645 |
| Genre | Journal Article Review |
| GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CGR CHBEP CIEJG CS3 CUY CVF CW9 DIK DU5 E3Z EBS ECM EIF EJD F5P FA0 FRP GX1 HYE NPM OK1 P2P RNS RPM TR2 XSB 7X8 |
| ID | FETCH-LOGICAL-c326t-b2fb34a7d81d898c88cb892d09d2f120311424d5cb5bfb49a8f2b0df12bb16b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 49 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000604330200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2219-2840 |
| IngestDate | Sun Nov 09 13:21:57 EST 2025 Thu Apr 03 07:09:34 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 39 |
| Keywords | Test accuracy Treatment Diagnosis Liver fibrosis Non-alcoholic fatty liver disease Clinical assessment |
| Language | English |
| License | The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-b2fb34a7d81d898c88cb892d09d2f120311424d5cb5bfb49a8f2b0df12bb16b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7584064 |
| PMID | 33132645 |
| PQID | 2456854159 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2456854159 pubmed_primary_33132645 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-Oct-21 20201021 |
| PublicationDateYYYYMMDD | 2020-10-21 |
| PublicationDate_xml | – month: 10 year: 2020 text: 2020-Oct-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World J Gastroenterol |
| PublicationYear | 2020 |
| SSID | ssj0023352 |
| Score | 2.5113368 |
| SecondaryResourceType | review_article |
| Snippet | Non-alcoholic fatty liver disease (NAFLD) is among the most frequent etiologies of cirrhosis worldwide, and it is associated with features of metabolic... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 5919 |
| SubjectTerms | Biopsy Elasticity Imaging Techniques Humans Liver - diagnostic imaging Liver - pathology Liver Cirrhosis - diagnosis Liver Cirrhosis - pathology Liver Cirrhosis - therapy Non-alcoholic Fatty Liver Disease - diagnostic imaging Non-alcoholic Fatty Liver Disease - therapy Prognosis |
| Title | Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33132645 https://www.proquest.com/docview/2456854159 |
| Volume | 26 |
| WOSCitedRecordID | wos000604330200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwEK_ykpFY3caOE9sTQoiKhapDhzJFdhyjIEgKCUX8e85JWjaExJIlsZKc7unv_B1CV1xS7mymSGikJlwIRWQqOAlEJmnGKTVcN8MmxHgsZzM16Tbcqq6tcukTG0dty9TvkQ89QCcjCDfqev5G_NQoj652IzTWUS-EVMZrtZitUATmzxP54XJglQTccNDClJ5wZfj5_DRYsHiQg65Eiv6SYDaBZrTz30_cRdtdiolvWp3YQ2tZsY8eOwLQF6xXXJxYFxa_rvpfcOnwi2_TwA5q6LLKK5wXuCgLots5unmKna7rr-6pDts5QNPR3fT2nnRjFUgKuVpNDHMm5FpYSFWlkqmUqZGK2UBZ5igDK_en32yUmsg4w5WWjpnAwi1jaGzYIdqAV2fHCBuoBi0DPwW_zGMT69hyITNPkyZsTF0fXS4FlYDWeihCF1n5USU_ouqjo1baybyl10hCzyYZ8-jkD6tP0RbzBTAEE0bPUM-BzWbnaDNd1Hn1ftGoA1zHk4dvo2jAHQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+assessment+and+management+of+liver+fibrosis+in+non-alcoholic+fatty+liver+disease&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Campos-Murgu%C3%ADa%2C+Alejandro&rft.au=Ruiz-Marg%C3%A1in%2C+Astrid&rft.au=Gonz%C3%A1lez-Regueiro%2C+Jos%C3%A9+A&rft.au=Mac%C3%ADas-Rodr%C3%ADguez%2C+Ricardo+U&rft.date=2020-10-21&rft.eissn=2219-2840&rft.volume=26&rft.issue=39&rft.spage=5919&rft_id=info:doi/10.3748%2Fwjg.v26.i39.5919&rft_id=info%3Apmid%2F33132645&rft_id=info%3Apmid%2F33132645&rft.externalDocID=33132645 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2219-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2219-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2219-2840&client=summon |